Standardized to the Serum Amyloid A (SAA) 1st International Standard (NIBSC code: 92/680) of the WHO (World Health Organisation).

Kinetic UDR Immunoassay, enhanced with polystyrene particles, for their use on Beckman Coulter's IMMAGE® 800 Immunochemical Systems.

Immunoassay enhanced with polystyrene particles, for their use on Clinical Chemistry automatic analyzers.

Applications available for the most common analyzers of Clinical Chemistry. For example Advia®, Alinity C, AU®, Atellica™, cobas® C, Optilite® or Mindray among others.

Clinical Significance of Serum Amyloid A (SAA)

Measuring SAA levels may be a useful indicator of the response to therapy and degree of acute and chronic inflammation, due to any inflammatory disorder, such as rheumatoid arthritis, juvenile arthritis, ankylosing spondylitis, familial Mediterranean fever, progressive sclerosis as well as bacterial infections.

Secondary amyloidosis may develop as a result of prolonged or repeated inflammatory conditions in which SAA levels remain elevated.

Serum Amyloid A (SAA), Acute and chronic inflammation, Inflammatory disorders, Covid-19, WHO code 92/680, IMMAGE ® Beckman Coulter, Atellica™ Siemens Healthineers, Optilite ® The Binding Site, PENIA, TIA.